Table 1. Baseline characteristics of men with PCa in our cohort as well as histopathology results, by upgrade status.
GS upgrade (n = 56 34%) |
GS no-upgrade (n = 110 66%) |
P-value | |
---|---|---|---|
Mean age (SD) | 67.1 (6.8) | 64.9 (7.0) | 0.06* |
Mean PSA (SD) | 8.85 (4.1) | 7.7 (5.5) | 0.21* |
% of positive cores at initial biopsy (%) | 15.1 (10.1) | 14.3 (10.9) | 0.64* |
% of positive cores at confirmatory biopsy (%) | 21.6 (15.6) | 7.1 (9.4) | <0.01* |
Ethnicity | |||
White | 38 (67.8%) | 77 (70%) | 0.37** |
Black | 10 (17.8%) | 24 (21.8%) | |
Asian | 2 (3.5%) | 2 (1.81%) | |
Mixed | 0 | 3 (2.71%) | |
Other/missing | 5 (8.9%) | 4 (3.63%) | |
Gleason score | |||
3+3 | 0 (0%) | 73 (66.3%) | <0.01** |
3+4 | 42 (75.0%) | 0 (0%) | |
4+3 | 11 (19.6%) | 0 (0%) | |
4+5 | 3 (5.4%) | 0 (0%) | |
2+3 | 0 (0%) | 1 (0.9%) | |
Benign | 0 (0%) | 23 (20%) | |
HGPIN | 0 (0%) | 13 (11.8%) |
T-test.
Chi-Square Test.